Quest Diagnostics, Inc. (DGX) Tops Q1 EPS by 6c; Raises FY12 Outlook
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q1 EPS of $1.07, $0.06 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.88 billion.
Raises its FY12 EPS guidance to $4.45-$4.60, which compares to the Street estimate of $4.54. The company previously guided to $4.40-$4.55.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Raises its FY12 EPS guidance to $4.45-$4.60, which compares to the Street estimate of $4.54. The company previously guided to $4.40-$4.55.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
